Quantcast

Latest Pharmacology Stories

2014-10-30 12:30:38

MUMBAI, India, October 30, 2014 /PRNewswire/ -- Net Profit for the second quarter increases by 7% to Rs 1650.78 Mn Business Highlights - India Business grew by 14.48 % to Rs. 4,781.50 Mn - Latin America Business grew by 139.01 % to Rs. 2,308.80 Mn - Europe Formulations Business grew by 25.06% to Rs. 1,305.53 - API Business grew by 57.85 % to Rs. 1,595.44 Glenmark Pharmaceuticals Limited, the research-led global...

2014-10-30 12:30:09

PITTSBURGH, Oct. 30, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Nevirapine Extended-release tablets, 400 mg, which is the generic version of Boehringer Ingelheim's Viramune XR(®). Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for combination antiretroviral (ARV) treatment of HIV-1 infection in adults and in children six to...

2014-10-30 12:26:53

High-Priced Specialty Medications Highlight Need for Pharmacy "Lock-In" Program in Medicare WASHINGTON, Oct. 30, 2014 /PRNewswire-USNewswire/ -- As policymakers examine ways to curb the prescription drug abuse epidemic, a new report by the National Center for Policy Analysis (NCPA), "Medicare Drug Plans Need the Tools to Fight Prescription Drug Fraud," recommends allowing drug plans and beneficiaries to choose pharmacies to obtain prescriptions for commonly abused drugs, a policy...

2014-10-30 12:26:34

LONDON, Oct. 30, 2014 /PRNewswire/ -- The Global Pre-filled Syringe Market 2014-2024 report analyses how this important sub-sector will continue to grow across the next decade. The report highlights key companies, geographies and products that we believe will deliver double digit growth across the next decade.Buy this report today and acquire analysis of the state of the pre-filled syringes market in 2014 and a market forecastfor the period 2014-2024. Market forecasts are also...

2014-10-30 12:22:07

Leading Marijuana Resource Site to Expand National Safe Transportation Campaign IRVINE, Calif., Oct. 30, 2014 /PRNewswire/ -- Weedmaps, the world's largest online medical and recreational marijuana resource, today announced a partnership with Curb, the taxi app that connects riders to a nationwide network of professional drivers, to promote safe transportation for marijuana users. Through the campaign, first time Curb users can use the promo code "WEEDMAPS" to receive $15 off their...

2014-10-30 08:37:03

GeneSight® Psychotropic Test Doubles the Likelihood of Remission and Response for Patients with Depression; Lowers Healthcare Costs MASON, Ohio, Oct. 30, 2014 /PRNewswire/ -- The promise of genetic testing to guide more effective treatment for millions of older and disabled Americans suffering from depression has shifted from a futuristic vision to a practical reality. http://photos.prnewswire.com/prnvar/20130910/CL75944LOGO Assurex Health today announced that Medicare has...

2014-10-30 08:37:00

Morrissey Built the #1 Vaporizer Brand With $8.5 Million in Sales in First Year LOS ANGELES, Oct. 30, 2014 /PRNewswire/ -- Medbox, Inc. (OTCQB: MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, is proud to announce the addition of Tim Morrissey to lead Medbox's wholly owned subsidiary, Vaporfection International, Inc., as Director and Vice-President. Mr. Morrissey is the founder and...

2014-10-30 08:36:57

CORAL SPRINGS, Florida, October 30, 2014 /PRNewswire/ -- Heavy demand continues for Marijuana industry specific technology and climate control services for Cannabis operations as more U.S. states move towards legalization and acceptance with approaching elections. Companies in focus today are: Surna Inc. (OTC: SRNA), Growblox Sciences Inc. (OTC: GBLX), Hemp, Inc. (OTC: HEMP), GreenGro Technologies Inc. (OTC: GRNH) and Medical Marijuana Inc. (OTC: MJNA) Surna Inc....

2014-10-30 08:36:43

SAN FRANCISCO, Oct. 30, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2014 on Thursday, November 6, 2014, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). The press release and a live audio-only Webcast of the conference call...

2014-10-30 08:36:39

NOTTINGHAM, United Kingdom, Oct. 30, 2014 /PRNewswire/ -- Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX) and Maryland-based Xceleron have announced a collaboration to assist drug developers with improved efficiency during clinical development that will be launched at AAPS in San Diego next week. This partnership extends Molecular Profiles' new ROADMAP to Clinical Trials enabling technologies platform, which it launched earlier this month. The...


Latest Pharmacology Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

0_3ff7149ca288229c28bcd855846ea8c7
2009-04-28 16:00:11

Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...

31_c737ff73aa3c47be364b2a8cce214e0c
2005-07-12 18:32:21

Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.

More Articles (5 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related